Guideline Recommendations for Management of Chronic Foley Catheter‑Associated Urinary Tract Infection

Catheter Management

Replace a Foley catheter that has been in place for ≥ 2 weeks before initiating antimicrobial therapy to accelerate symptom resolution and lower the risk of subsequent bacteriuria. 1
Obtain a urine culture from the newly placed catheter rather than the old one, because biofilm on the existing catheter does not reliably represent bladder infection. 1
Perform the urine culture prior to starting antibiotics to account for the broad range of possible pathogens and the high likelihood of antimicrobial resistance. 1

Fluoroquinolones are the preferred empirical agents, achieving superior microbiologic eradication (≈ 79 % vs 53 % with ciprofloxacin). 1
Levofloxacin 750 mg IV or PO once daily is specifically supported for catheter‑associated UTI. 1

Ceftriaxone IV is recommended as the empirical choice for patients requiring intravenous therapy who do not have multidrug‑resistance risk factors. 3
Antipseudomonal agents should be reserved only for patients with documented risk factors for nosocomial pathogens (e.g., prior ICU stay, recent broad‑spectrum antibiotic exposure). 3
Carbapenems may be used empirically only when multidrug‑resistance risk factors are present. 3

Moxifloxacin should be avoided because urinary concentrations sufficient for treatment are uncertain. 1

7 days of therapy for patients who experience prompt symptom resolution, irrespective of whether the catheter remains in place. 1
10–14 days for patients with delayed clinical response. 1
A 5‑day levofloxacin regimen can be considered in non‑severely ill patients when rapid response is anticipated. 1

De‑escalate (narrow) antimicrobial therapy based on culture and susceptibility results as soon as they become available. 1
Extend the duration of therapy and arrange urologic evaluation if the clinical response is inadequate. 1
Prefer shorter effective courses whenever possible to limit the development of antimicrobial resistance. 1